L. Groşeanu

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Low vitamin D status in systemic sclerosis and the impact on disease phenotype

Tania Gudu, Cosmin Constantinescu, Ruxandra Ionescu et al. · European Journal of Rheumatology · 2016 · 52 citations · Full text

Medicine, Immunology, Autoimmunity +16

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, Michael Putman et al. · The Lancet Rheumatology · 2021 · 51 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Monitoring Drug and Antidrug Levels: A Rational Approach in Rheumatoid Arthritis Patients Treated with Biologic Agents Who Experience Inadequate Response While Being on a Stable Biologic Treatment

Diana Mazilu, Daniela Opriș-Belinski, C. Gainaru et al. · BioMed Research International · 2014 · 41 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

Carina Mihai, Oliver Distler, Ana Maria Gheorghiu et al. · Lara D. Veeken · 2019 · 29 citations

Veterinary Medicine, Pathology, Clinical Classification Systems +15